Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722341 · ClinicalTrials.gov registry record · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
A NA study of Breast Cancer and Colorectal Cancer, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 2
- Study locations
NCT04722341 is a NA study of Breast Cancer and Colorectal Cancer that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 175 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04722341, a NA study of Breast Cancer and Colorectal Cancer, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Time-Restricted Eating (TRE)
Study Locations (2)
Alabama
- The University of Alabama at Birmingham - Birmingham
California
- Cedars-Sinai Medical Center - West Hollywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04722341
The ClinicalTrials.gov registry entry for NCT04722341 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT04722341 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, California.
Frequently Asked Questions
What is clinical trial NCT04722341 about?
NCT04722341 is a clinical study titled "Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators". The purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.
What is the current status of trial NCT04722341?
This trial is currently recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2022-01-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04722341 study?
This clinical trial studies the following conditions: Breast Cancer, Colorectal Cancer.
What interventions are being tested in trial NCT04722341?
The interventions under investigation include: Control (BEHAVIORAL), Time-Restricted Eating (TRE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04722341?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04722341 being conducted?
This trial has 2 study locations across Alabama, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.